<?xml version="1.0" encoding="UTF-8"?>
<p>Since the outbreak of severe acute respiratory syndrome (SARS)-CoV-2 or COVID-19 coronavirus started in China in December 2019, there is increasing evidence that those with existing comorbidities, older age or a compromised immune system are at higher risk of developing severe and even fatal respiratory diseases [
 <xref rid="ref1" ref-type="bibr">1</xref>]. Cancer and transplant patients are also considered to be in this risk group [
 <xref rid="ref2" ref-type="bibr">2</xref>, 
 <xref rid="ref3" ref-type="bibr">3</xref>], especially as they may be treated with immune-suppressive or immune-stimulating drugs.
</p>
